PGE2, a prostanoid synthesized by COX-2, binds to EP4 receptors in the prostate tissue, inducing prostatic inflammation and contributing to lower urinary tract symptoms in BPH [33]. This evidence concerns the gene PTGS2 and benign prostatic hyperplasia.